bufalin has been researched along with nintedanib in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Liu, Q; Liu, Y; Lu, S; Shi, F; Xu, W; Xu, Y | 1 |
| Chen, P; Lu, S; Pan, B; Xu, Y | 1 |
2 other study(ies) available for bufalin and nintedanib
| Article | Year |
|---|---|
Co-delivery of bufalin and nintedanib via albumin sub-microspheres for synergistic cancer therapy.
Topics: Albumins; Antineoplastic Combined Chemotherapy Protocols; Bufanolides; Drug Synergism; Humans; Indoles; Microspheres; Neoplasms; Tumor Microenvironment | 2021 |
Development, Optimization, and Pharmacokinetics Study of Bufalin/Nintedanib Co-loaded Modified Albumin Sub-microparticles Fabricated by Coaxial Electrostatic Spray Technology.
Topics: Albumins; Bufanolides; Drug Carriers; Indoles; Nanoparticles; Static Electricity; Technology | 2021 |